Evidence map›Paper›PMID 24615748›Full record

GuidelineCancer2014

MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.

Rajesh V Lalla, Joanne Bowen, Andrei Barasch, Linda Elting, Joel Epstein, Dorothy M Keefe, Deborah B McGuire, Cesar Migliorati, Ourania Nicolatou-Galitis, Douglas E Peterson and 4 more

Erratum issued 6 registry-linked trialsOpen access · hybridAbstract readPractice GuidelineSystematic Review
In one paragraph

Guideline in Cancer, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. It is linked to 6 registered trials, which are not on this map. Cited by 433 papers, 16 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
433citing papers in PubMed, 16 pooled it
65.9field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03203733 nacompletednot on this mapstarted 2017, after this paper: background citation

Cryoprotection of Chemotherapy-induced Oral Mucositis After Autologous Stem Cell Transplantation, a Randomized Study

TypeinterventionalSponsorUppsala UniversityRan2017 to 2019Enrolled182ConditionsCryotherapy EffectArmsCooral™, cryotherapy
NCT04221165 phase2completednot on this mapstarted 2020, after this paper: background citation

Opioid Therapy vs Multimodal Analgesia in Head and Neck Cancer: A Randomized Clinical Trial

TypeinterventionalSponsorLondon Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph'sRan2020 to 2023Enrolled49ConditionsHead and Neck Cancer, Radiation-Induced MucositisArmsOpioids, PAiN - multimodal analgesia
NCT05104268 early_phase1withdrawnnot on this mapstarted 2024, after this paper: background citation

A Randomized Study of a New Medical Device for Oral Mucositis (MDOM Trial)

TypeinterventionalSponsorE2Bio Life Sciences, LLCRan2024 to 2025Enrolled0ConditionsOral Mucositis, Stem Cell Transplant ComplicationsArmsBocaliner
NCT05308732 phase1active not recruitingnot on this mapstarted 2021, after this paper: background citation

Phase I Study of Multiple Ascending Dose, to Investigate the Safety and Tolerability of the Use of Copaiba in Patients With Oral Cancer Submitted to Radiotherapy

TypeinterventionalSponsorInstituto Nacional de Cancer, BrazilRan2021 to 2026Enrolled20ConditionsHead and Neck Neoplasms, Mucositis Oral, Radiotherapy, ComplicationsArmsCopaiba
NCT05338398 phase1 / phase2unknown statusnot on this mapstarted 2022, after this paper: background citation

A Phase 1/Phase 2 Study for the Prevention of Oral Mucositis (SPOM)

TypeinterventionalSponsorE2Bio Life Sciences, LLCRan2022 to 2023Enrolled100ConditionsOral MucositisArmsBocaliner, Benzydamine
NCT06071637 phase3recruitingnot on this mapstarted 2023, after this paper: background citation

Low Power Laser Therapy As Prevention Of Oral Mucositis And Oropharyngeal Pain In Patients Undergoing Allogenetic Hematopoietic Stem Cell Transplantation.

TypeinterventionalSponsorInstituto Nacional de Cancer, BrazilRan2023 to 2027Enrolled84ConditionsHematopoietic Stem Cell Transplantation, Low-Level Light Therapy, StomatitisArmsDouble low-power laser therapy simultaneous applicated
3 · Its place in the literature

Who cites it

433 citing papers in PubMed, 16 syntheses or guidelines pooled it, 1,079 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Systematic review of prophylactic antibacterial agents for radiation-induced oral mucositis in head and neck cancer.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Pooled it
  4. Guideline
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Efficacy of photobiomodulation in the treatment of oral mucositis in patients undergoing antineoplastic therapy: systematic review and meta-analysis.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2023
    Pooled it
  9. Pooled it
  10. Efficacy of oral and topical antioxidants in the prevention and management of oral mucositis in head and neck cancer patients: a systematic review and meta-analyses.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2022
    Pooled it
  11. Pooled it
  12. Pooled it
  13. Pooled it
  14. Pooled it
  15. Microbiome-gut-brain axis in cancer treatment-related psychoneurological toxicities and symptoms: a systematic review.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Pooled it
  16. Eficacy of Cryotherapy in the Prevention of Oral Mucosistis in Adult Patients with Chemotherapy.International journal of environmental research and public health · 2021
    Pooled it
  17. Acceptance and perceived efficacy of intraoral versus extraoral photobiomodulation for oral mucositis prevention in pediatric patients.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2026
    Trial
  18. Trial
  19. Trial
  20. Trial

373 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

  • Erratum issued
5 · Who and what money

Authors and funding

14 authors at 11 institutions in 4 countries.

Rajesh V LallaUniversity of Connecticut, Farmington, Connecticut.
Joanne Bowen
Andrei Barasch
Linda Elting
Joel Epstein
Dorothy M Keefe
Deborah B McGuire
Cesar Migliorati
Ourania Nicolatou-Galitis
Douglas E Peterson
Judith E Raber-Durlacher
Stephen T Sonis
Sharon Elad
Mucositis Guidelines Leadership Group of the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)
University of Adelaide · AUUniversity of Connecticut · USAcademic Medical Center · NLBrigham and Women's Hospital · USCity Of Hope National Medical Center · USNational and Kapodistrian University of Athens · GRThe University of Texas MD Anderson Cancer Center · USUniversity of Rochester · USUniversity of Tennessee Health Science Center · USVirginia Commonwealth University · USWinthrop-University Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMucositis is a highly significant, and sometimes dose-limiting, toxicity of cancer therapy. The goal of this systematic review was to update the Multinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO) Clinical Practice Guidelines for mucositis.

methodsA literature search was conducted to identify eligible published articles, based on predefined inclusion/exclusion criteria. Each article was independently reviewed by 2 reviewers. Studies were rated according to the presence of major and minor flaws as per previously published criteria. The body of evidence for each intervention, in each treatment setting, was assigned a level of evidence, based on previously published criteria. Guidelines were developed based on the level of evidence, with 3 possible guideline determinations: recommendation, suggestion, or no guideline possible.

resultsThe literature search identified 8279 papers, 1032 of which were retrieved for detailed evaluation based on titles and abstracts. Of these, 570 qualified for final inclusion in the systematic reviews. Sixteen new guidelines were developed for or against the use of various interventions in specific treatment settings. In total, the MASCC/ISOO Mucositis Guidelines now include 32 guidelines: 22 for oral mucositis and 10 for gastrointestinal mucositis. This article describes these updated guidelines.

conclusionsThe updated MASCC/ISOO Clinical Practice Guidelines for mucositis will help clinicians provide evidence-based management of mucositis secondary to cancer therapy.

Indexed as

Oral HygieneAmifostineAnalgesicsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAnti-Ulcer AgentsCryotherapyCytokinesEsophagitisEvidence-Based MedicineHumansHyperbaric OxygenationIntercellular Signaling Peptides and ProteinsLow-Level Light TherapyMucositisAmifostineAnalgesicsAnti-Infective AgentsAnti-Inflammatory AgentsAntineoplastic AgentsAnti-Ulcer AgentsCytokinesIntercellular Signaling Peptides and ProteinsProtective AgentsRadiation-Protective AgentsSucralfategastrointestinalguidelinesmucositisMultinational Association of Supportive Care in Cancer and International Society of Oral Oncology (MASCC/ISOO)oralstomatitis

Identifiers

PMID24615748
PMCPMC4164022
OpenAlexW3190697283

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.